<DOC>
	<DOC>NCT01082445</DOC>
	<brief_summary>The purpose of this study is to determine whether N-acetylcysteine is effective in the treatment or prevention of the foot ulcers in diabetic patients.</brief_summary>
	<brief_title>Effects of N-acetylcysteine on Diabetic Foot Oxygenation</brief_title>
	<detailed_description />
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Age between 45 and 70 years. Type 1 or 2 diabetes mellitus with foot ulcer (grade 0 stage C according to Texas University Classification). Written informed consent. Nacetylcysteine assumption in the 6 months previous to the study. Hypersensibility to acetylcysteine. Neoplasms, severe systemic, hepatic, pulmonary, cardiovascular or renal diseases. Psychiatric diseases or drug abuse problems.</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>stage C</keyword>
	<keyword>grade 0 (Texas University)</keyword>
</DOC>